Scarica l'app Stockscreener
0.975
0.51%
-0.005
Dopo l'orario di chiusura:
.99
0.015
+1.54%
Precedente Chiudi:
$0.98
Aprire:
$0.97
Volume 24 ore:
3.25M
Relative Volume:
3.92
Capitalizzazione di mercato:
$35.08M
Reddito:
$25.24M
Utile/perdita netta:
$-8.38M
Rapporto P/E:
-4.2391
EPS:
-0.23
Flusso di cassa netto:
$-9.54M
1 W Prestazione:
-46.72%
1M Prestazione:
-51.25%
6M Prestazione:
-84.32%
1 anno Prestazione:
-74.00%
Intervallo 1D:
$0.9245
$0.9982
Intervallo di 1 settimana:
$0.9245
$1.84
Portata 52W:
$0.9245
$7.1699
Myomo Inc Stock (MYO) Company Profile
Nome
Myomo Inc
Settore
Industria
Telefono
617-996-9058
Indirizzo
One Broadway, 14th Floor, Cambridge, MA
Confronta MYO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
0.975 | 37.05M | 25.24M | -8.38M | -9.54M | -0.23 |
|
ABT
Abbott Laboratories
|
131.75 | 225.01B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 154.32B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.91 | 144.71B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.02 | 117.85B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.26 | 45.90B | 5.69B | 1.41B | 577.90M | 6.95 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Iniziato | Craig Hallum | Buy |
| 2024-05-20 | Iniziato | Lake Street | Buy |
| 2023-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2020-05-27 | Iniziato | Dougherty & Company | Buy |
| 2017-10-02 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Myomo Inc Borsa (MYO) Ultime notizie
Why Medical Device Maker Myomo’s Stock Crashed 42% In After-Hours Trading - Stocktwits
HC Wainwright & Co. Maintains 'Buy' Rating for Myomo (MYO), Lowers Price Target to $5.00 - AInvest
Myomo Reports 28% Revenue Growth, Faces Operational Challenges - AInvest
Myomo price target lowered to $5 from $9.50 at H.C. Wainwright - MSN
Myomo, Inc. (NYSE:MYO) Q2 2025 Earnings Call Transcript - Insider Monkey
Myomo Inc (MYO) Q2 2025 Earnings Call Highlights: Revenue Surge Amid Rising Costs and Strategic ... - Yahoo Finance
Myomo, Inc. shares fall 40.34% intraday after reporting Q2 2025 financial results. - AInvest
Myomo Raises 2025 Revenue Growth Target to 23% to 29% - AInvest
Myomo (MYO.A) Plummets 39.5%: Technicals, Order Flow, and Sector Clues Point to Liquidity Pressure - AInvest
Myomo's 39.77% Plunge: Earnings Triumph or Market Rejection? - AInvest
MYO Earnings: Guidance Cut Slams Myomo Stock - TipRanks
Myomo revenue up 28% to USD 9.7 million in Q2 2025 - Medical Buyer
Myomo Shares Plunge Over 42% Pre-Market Despite Q2 Revenue Beat Amid Weak Outlook, Rising Losses - Benzinga
Myomo Stock Plunges 37.5% on Revenue Forecast Cut - AInvest
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates - MSN
Myomo Q2 2025 Earnings Call Transcript - MarketBeat
Myomo, Inc. Reports Q2 2025 Financial Results - TipRanks
Why Myomo Inc. stock attracts strong analyst attentionLightning Profit Stock Alerts - thegnnews.com
Myomo outlines revised 2025 revenue growth target of 23%-29% as lead quality and pipeline conversion shift - MSN
Myomo (MYO) Reports 28% Revenue Growth in Q2 2025, Faces Operati - GuruFocus
Myomo's (MYO) Revenue Growth vs. Burn Rate and IT Risks: A Balancing Act for Long-Term Value - AInvest
Earnings call transcript: Myomo Q2 2025 results show revenue growth - Investing.com
Myomo earnings missed, revenue topped estimates By Investing.com - Investing.com Nigeria
Myomo earnings missed, revenue topped estimates - Investing.com
Myomo Reports Second Quarter 2025 Financial and Operating Results - Yahoo Finance
Myomo Q2 Earnings Preview: Revenue Growth Expected Despite EPS Decline - AInvest
Myomo's Q2 Earnings Preview: Analysts Expect $-0.11 EPS, Guidance Key to Stock Price - AInvest
Should I set a stop loss on Myomo Inc.Huge Yield Momentum Trades - mustnews.co.kr
Analysts Offer Insights on Healthcare Companies: Myomo (MYO), Quoin Pharmaceuticals (QNRX) and RegenXBio (RGNX) - The Globe and Mail
Myomo Reveals its $100 Revenue Goal During Investor Day - MSN
Earnings To Watch: Myomo Inc (MYO) Reports Q2 2025 Result - Yahoo Finance
Myomo to Announce Q2 2025 Financial Results on August 11. - AInvest
Myomo to Report Second Quarter 2025 Financial Results on August 11 - Yahoo Finance
What are the latest earnings results for Myomo Inc.Rapid wealth accumulation - Jammu Links News
Is Myomo Inc. a good long term investmentExceptional profit potential - Jammu Links News
What catalysts could drive Myomo Inc. stock higher in 2025Achieve rapid returns with smart investment plans - Jammu Links News
What drives Myomo Inc. stock priceCapital growth strategies that work - Jammu Links News
Does Myomo Inc. stock perform well during market downturnsExceptional trading results - Jammu Links News
Published on: 2025-08-03 13:31:54 - Jammu Links News
What are analysts’ price targets for Myomo Inc. in the next 12 monthsGet timely alerts on top market movers - Jammu Links News
What analysts say about Myomo Inc. stockDouble or triple returns - Jammu Links News
How does Myomo Inc. compare to its industry peersHigh-profit trading signals - Jammu Links News
What is the dividend policy of Myomo Inc. stockAchieve breakthrough investment performance - Jammu Links News
What is Myomo Inc. company’s growth strategyUnlock high-yield investment opportunities - Jammu Links News
When is Myomo Inc. stock expected to show significant growthAchieve superior capital gains with smart trades - Jammu Links News
Should I hold or sell Myomo Inc. stock in 2025Invest smarter with expert stock picks - Jammu Links News
Is Myomo Inc. stock overvalued or undervaluedGet exclusive access to professional stock picks - Jammu Links News
How many analysts rate Myomo Inc. as a “Buy”Invest confidently with professional market insights - Jammu Links News
Can Myomo Inc. recover in the next quarterAccurate Forecast System with AI Support - Newser
Bollinger Bands Show Potential Breakout in Myomo Inc.Risk Adjusted Technical Entry Plan Gains Followers - metal.it
Risk vs reward if holding onto Myomo Inc.Stable Profit Zone and Loss Control Analysis - Newser
Myomo Inc Azioni (MYO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.74%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):